Imagion Biosystems Ltd (IBX) - Total Liabilities

Latest as of December 2025: AU$4.21 Million AUD ≈ $2.98 Million USD

Based on the latest financial reports, Imagion Biosystems Ltd (IBX) has total liabilities worth AU$4.21 Million AUD (≈ $2.98 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore IBX shareholders equity momentum to track the company's year-over-year net asset growth rate.

Imagion Biosystems Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Imagion Biosystems Ltd's total liabilities have evolved over time, based on quarterly financial data.

Imagion Biosystems Ltd Competitors by Total Liabilities

The table below lists competitors of Imagion Biosystems Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
TAIZHOU WATER GRP. H YC 1 F:GX5	Germany	€4.29 Billion
Zeb Nickel Corp V:ZBNI	Canada	CA$2.35 Million
Sulliden Minerals SA TO:SMC	Canada	CA$2.72 Million
Click Holdings Limited NASDAQ:CLIK	USA	$2.55 Million
FATHOM NICKEL INC. F:6Q5	Germany	€163.50K
Lion Energy Ltd AU:LIO	Australia	AU$2.85 Million
Danasupra Erapacific Tbk JK:DEFI	Indonesia	Rp2.69 Billion
Rare Earth Magnesium Technology Group Holdings Limited STU:GPS	Germany	€895.62 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Imagion Biosystems Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IBX company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.95	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	2.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Imagion Biosystems Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Imagion Biosystems Ltd (2014–2025)

The table below shows the annual total liabilities of Imagion Biosystems Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	AU$4.21 Million ≈ $2.98 Million	-17.31%
2024-12-31	AU$5.09 Million ≈ $3.60 Million	-39.26%
2023-12-31	AU$8.37 Million ≈ $5.93 Million	+58.06%
2022-12-31	AU$5.30 Million ≈ $3.75 Million	+554.19%
2021-12-31	AU$809.88K ≈ $573.04K	-32.80%
2020-12-31	AU$1.21 Million ≈ $852.71K	-36.52%
2019-12-31	AU$1.90 Million ≈ $1.34 Million	+44.02%
2018-12-31	AU$1.32 Million ≈ $932.73K	+91.39%
2017-12-31	AU$688.77K ≈ $487.35K	+52.39%
2016-12-31	AU$451.99K ≈ $319.81K	-95.32%
2015-12-31	AU$9.65 Million ≈ $6.83 Million	+123.93%
2014-12-31	AU$4.31 Million ≈ $3.05 Million	--

About Imagion Biosystems Ltd

AU:IBX Australia Diagnostics & Research

Market Cap

$4.17 Million

AU$5.89 Million AUD

Market Cap Rank

#28888 Global

#1574 in Australia

Share Price

AU$0.01

Change (1 day)

-7.69%

52-Week Range

AU$0.01 - AU$0.05

All Time High

AU$8.60